Travere Therapeutics
The Executive Director, Clinical Development leads clinical trials in rare kidney diseases, shaping and executing development strategies with a focus on scientific rigor and patient-centered approaches. This role involves collaborating with cross-functional teams, managing program risks, and representing Clinical Development in regulatory interactions. The position requires a medical degree with advanced nephrology training and extensive experience in clinical research and drug development.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
24% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Scientific Lead, Nephrology
Jobgether
Senior Medical Specialist, Therapeutic Areas - Global Clinical Development
Lundbeck
Executive Medical Director, Clinical Development, Hematology, Nephrology, & Transplant, Cell Therapy
AstraZeneca
Senior Clinical Scientist
Jade Biosciences
Senior MSL – Rare Diseases (Haematology, Nephrology and Transplant)
AstraZeneca
Vice President, Clinical Development Program Leader
Madrigal Pharmaceuticals